APOLLOMICS
Apollomics, Inc. is an innovative biopharmaceutical company committed to the discovery and development of mono- and combination- oncology therapies to harness the immune system and target specific molecular pathways to eradicate cancer. The companyโs existing pipeline consists of several development-stage assets, including novel, humanized monoclonal antibodies that restore the bodyโs immune system to recognize and kill cancer cells, and targeted therapies against uncontrolled growth signaling pathways.
APOLLOMICS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2016-01-01
Address:
Foster City, California, United States
Country:
United States
Website Url:
http://www.apollomicsinc.com
Total Employee:
11+
Status:
Active
Contact:
+1-650-209-4055
Total Funding:
238.95 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
![]()
Apellis Pharmaceuticals
Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
SalubrisBio
SalubrisBio is a clinical-stage biotechnology company dedicated to discovering and developing novel antibody and protein-based therapeutics.
Current Advisors List
![]()
Current Employees Featured
![]()
Founder
![]()
Investors List
Ping An Capital
Ping An Capital investment in Series C - Apollomics
CMB International Capital Corporation
CMB International Capital Corporation investment in Series B - Apollomics

Junson Capital
Junson Capital investment in Series B - Apollomics

Guangzhou Yue Min Investment
Guangzhou Yue Min Investment investment in Series B - Apollomics
![]()
OrbiMed
OrbiMed investment in Series B - Apollomics
K2VC
K2VC investment in Series B - Apollomics
South China Venture Capital
South China Venture Capital investment in Series B - Apollomics
Pan-Lin Capital
Pan-Lin Capital investment in Series B - Apollomics
![]()
OrbiMed
OrbiMed investment in Series A - Apollomics
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2019-01-17 | MabPlex International | Apollomics investment in Series A - MabPlex International | 400 M CNY |
Official Site Inspections
http://www.apollomicsinc.com
- Host name: 104.26.1.173
- IP address: 104.26.1.173
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
